Leon Moulder Oliver's most recent trade in Zai Lab Limited - ADR was a trade of 10,831 American Depositary Shares done . Disclosure was reported to the exchange on June 18, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Zai Lab Limited - ADR | Leon Oliver Moulder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2025 | 10,831 | 72,602 (0%) | 0% | 0 | American Depositary Shares | |
| Zenas Biopharma Inc. | Leon Oliver Moulder | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2025 | 400,000 | 400,000 | - | - | Stock Option (Right to Buy) | |
| Zenas Biopharma Inc. | Leon Moulder Oliver | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 6.67 per share. | 18 Feb 2025 | 25,000 | 266,155 | - | 6.7 | 166,750 | Common Stock |